ReviewFrontiers in immunology2026

Precise delivery and controlled release: strategies and advances in TLR7/8 agonist prodrugs for cancer immunotherapy.

Yutao Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.